Company intelligence / Profile preview

InheRET

New Haven, Connecticut, United States

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

InheRET offers a validated online platform that collects patient-entered personal and family health histories to assess genetic disease risks. The system generates reports to help clinicians identify patients who may benefit from further genetic evaluation or testing. Peer-reviewed studies have demonstrated its accuracy compared to traditional methods.

Therapeutic areas: OncologyRare Diseases
Modalities: Non-pharmacological therapy (digital health platform for genetic risk assessment)
Industry: Digital Health Medical Devices

Partnerships

Collaborations with academic medical centers, hospitals, and clinics using their software for clinical workflow integration

Beyond the preview

Go deeper on InheRET.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InheRET.

Explore the full profile